Quantitative and cost comparison of ultrasensitive human immunodeficiency virus type 1 RNA viral load assays: Bayer bDNA Quantiplex versions 3.0 and 2.0 and Roche PCR Amplicor monitor version 1.5

Journal of Clinical Microbiology

Volumn 38, Issue 3, 2000, Pages 1113-1120

  Elbeik, Tarek ^a,b   Charlebois, Edwin ^a   Nassos, Patricia ^a,b   Kahn, James ^a   Hecht, Frederick M ^a   Yajko, David ^a,b   Ng, Valerie ^a,b   Hadley, Keith ^a,b  

^a SAN FRANCISCO GENERAL HOSPITAL   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; VIRUS RNA;

ARTICLE; ASSAY; COST; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; VIRUS LOAD;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; RNA VIRUSES;

EID: 0034049471     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/jcm.38.3.1113-1120.2000     Document Type: Article

References (18)

1. Brambilla, D., S. Leung, J. Lew, J. Todd, S. Herman, M. Cronin, D. E. Shapiro, J. Bremer, C. Hanson, G. V. Hillyer, G. D. McSherry, R. S. Sperling, R. W. Coombs, and P. S. Reichelderfer. 1998. Absolute copy number and relative change in determinations of human immunodeficiency virus type 1 RNA in plasma: effect of an external standard on kit comparisons. J. Clin. Microbiol. 36:311-314.
2. Carpenter, C. C., M. A. Fischl, S. M. Hammer, M. S. Hirsch, D. M. Jacobsen, D. A. Katzenstein, J. S. Montaner, D. D. Richman, M. S. Saag, R. T. Schooley, M. A. Thompson, S. Vella, P. G. Yeni, and P. A. Volberding. 1998. Antiretroviral therapy for HIV infection in 1998: updated recommendations of the International AIDS Society-USA Panel. JAMA 280:78-86.
3. Chun, T. W., L. Stuyver, S. B. Mizell, L. A. Ehler, J. A. Mican, M. Baseler, A. L. Lloyd, M. A. Nowak, and A. S. Fauci. 1997. Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy. Proc. Natl. Acad. Sci. USA 94:13193-13197.
4. Collins, M. L., B. Irvine, D. Tyner, E. Fine, C. Zayati, C.-A. Chang, T. Horn, D. Ahle, J. Detmer, L.-P. Shen, J. Kolberg, S. Bushnell, M. S. Urdea, and D. D. Ho. 1997. A branched DNA signal amplification assay for quantification of nucleic acid targets below 100 molecules/ml. Nucleic Acids Res. 25:2979-2984.
5. Finzi, D., M. Hermankova, T. Pierson, L. M. Carruth, C. Buck, R. E. Chaisson, T. C. Quinn, K. Chadwick, J. Margolick, R. Brookmeyer, J. Gallant, M. Markowitz, D. D. Ho, D. D. Richman, and R. F. Siliciano. 1997. Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy. Science 278:1295-1300.
6. Fleiss, J. L. 1981. Statistical methods for rates and proportions, vol. xviii p. 321. Wiley, New York, N.Y.
7. Hodara, V., A. Monticelli, S. Pampuro, H. Salomón, H. Jauregui Rueda, and O. Libonatti. 1998. HIV-1 viral load: comparative evaluation of three commercially available assays in Argentina. Acta Physiol. Pharmacol. Ther. Latinoam. 48:107-113.
8. Kern, D., M. Collins, T. Fultz, J. Detmer, S. Hamren, J. J. Peterkin, P. Sheridan, M. Urdea, R. White, T. Yeghiazarian, and J. Todd. 1996. An enhanced-sensitivity branched-DNA assay for quantification of human immunodeficiency virus type 1 RNA in plasma. J. Clin. Microbiol. 34:3196-3202.
9. Lin, H. J., L. Pedneault, and F. B. Hollinger. 1998. Intra-assay performance characteristics of five assays for quantification of human immunodeficiency virus type 1 RNA in plasma. J. Clin. Microbiol. 36:835-839.
10. Natarajan, V., M. Bosche, J. A. Metcalf, D. J. Ward, H. C. Lane, and J. A. Kovacs. 1999. HIV-1 replication in patients with undetectable plasma virus receiving HAART. Lancet 353:119-120.
11. Nolte, F. S., J. Boysza, C. Thurmond, W. S. Clark, and J. L. Lennox. 1998. Clinical comparison of an enhanced-sensitivity branched-DNA assay and reverse transcription-PCR for quantitation of human immunodeficiency virus type 1 RNA in plasma. J. Clin. Microbiol. 36:715-720.
12. Notermans, D. W., S. Jurriaans, F. de Wolf, N. A. Foudraine, J. J. de Jong, W. Cavert, C. M. Schuwirth, R. H. Kauffmann, P. L. Meenhorst, H. McDade, C. Goodwin, J. M. Leonard, J. Goudsmit, and S. A. Danner. 1998. Decrease of HIV-1 RNA levels in lymphoid tissue and peripheral blood during treatment with ritonavir, lamivudine and zidovudine. Ritonavir/3TC/ZDV Study Group. AIDS 12:167-173.
13. Raboud, J. M., E. Seminari, S. L. Rae, P. R. Harrigan, R. S. Hogg, B. Conway, C. Sherlock, M. T. Schechter, M. V. O'Shaughnessy, and J. S. G. Montaner. 1998. Comparison of costs of strategies for measuring levels of human immunodeficiency virus type 1 RNA in plasma by using Amplicor and Ultra Direct assays. J. Clin. Microbiol. 36:3369-3371.
14. Segondy, M., J. Izopet, I. Pellegrin, B. Montes, B. Dumon, C. Pasquier, M. Peeters, H. J. Fleury, J. Puel, and J. Reynes. 1998. Comparison of the Quantiplex HIV-1 RNA 2.0 assay with the Amplicor HIV-1 Monitor 1.0 assay for quantitation of levels of human immunodeficiency virus type 1 RNA in plasma of patients receiving stavudine-didanosine combination therapy. J. Clin. Microbiol. 36:3392-3395.
15. Sun, R., J. Ku, H. Jayakar, J. C. Kuo, D. Brambilla, S. Herman, M. Rosenstraus, and J. Spadoro. 1998. Ultrasensitive reverse transcription-PCR assay for quantitation of human immunodeficiency virus type 1 RNA in plasma. J. Clin. Microbiol. 36:2964-2969.
16. Todd, J., C. Pachl, R. White, T. Yeghiazarian, P. Johnson, B. Taylor, M. Holdoniy, D. Kern, S. Hamren, D. Chernoff, and M. Urdea. 1995. Performance characteristics for the quantitation of plasma HIV-1 RNA using branched DNA signal amplification technology. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 10:S35-S44.
17. Triques, K., J. Coste, J. L. Perret, C. Segarra, E. Mpoudi, J. Reynes, E. Delaporte, A. Butcher, K. Dreyer, S. Herman, J. Spadoro, and M. Peeters. 1999. Efficiencies of four versions of the AMPLICOR HIV-1 MONITOR test for quantification of different subtypes of human immunodeficiency virus type 1. J. Clin. Microbiol. 37:110-116.
18. Vandamme, A. M., K. Van Vaerenbergh, and E. De Clercq. 1998. Antihuman immunodeficiency virus drug combination strategies. Antivir. Chem. Chemother. 9:187-203.